Source: Bloomberg
GlaxoSmithKline Plc hid the risks of its Avandia diabetes drug to protect more than $2 billion in annual sales, according to a lawsuit filed by a lawyer who has won multimillion-dollar verdicts against other drugmakers.
FULL STORY
If GlaxoSmithKline were a group of people living in a house they would be facing the death penalty what with hiding Avandia data and the Paxil Study 329. But, no, they are still allowed to walk the streets and continue manufacturing poor drugs which always seem to slip by the MHRA!
Fid
1 comment: